Gevo, Inc. (Gevo) is a renewable chemicals and next generation biofuels company. The Company has developed a technology that uses a combination of synthetic biology, metabolic engineering, chemistry and chemical engineering to focus primarily on the production of isobutanol, as well as related products from renewable feedstock. It has two operating segments: the Gevo, Inc. segment and the Gevo Development/Agri-Energy segment. Its Gevo, Inc. segment is responsible for research and development activities related to the future production of isobutanol, including the development of its biocatalysts, the production and sale of biojet fuel, its Retrofit process and the next generation of chemicals and biofuels that will be based on its isobutanol technology. Its Gevo Development/Agri-Energy segment is responsible for the operation of its Agri-Energy Facility and the production of ethanol, isobutanol and related products.
Industry, Sector and Symbol:
- Sector: Oils/Energy
- Industry: Renewable Fuels
- Sub-Industry: Oil & Gas Refining & Marketing
- Symbol: NASDAQ:GEVO
- CUSIP: 37439610
- Web: www.gevo.com
Capitalization:- Market Cap: $12 million
- Outstanding Shares: 16,212,000
Average Prices:- 50 Day Moving Avg: $0.60
- 200 Day Moving Avg: $0.79
- 52 Week Range: $0.53 - $10.40
P/E:- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -0.95
- P/E Growth: -0.0200
Sales & Book Value:- Annual Revenue: $25.94 million
- Price / Sales: 0.46
- Book Value: $4.17 per share
- Price / Book: 0.18
Profitability:- EBIDTA: ($19,180,000.00)
- Net Margins: -108.84%
- Return on Equity: -43.79%
- Return on Assets: -28.59%
Debt:- Debt-to-Equity Ratio: 0.20%
- Current Ratio: 1.45%
- Quick Ratio: 1.18%
Misc:- Average Volume: 466,366 shs.
- Beta: 2.91
- Short Ratio: 2.63
Frequently Asked Questions for Gevo (NASDAQ:GEVO)
What is Gevo's stock symbol?
Gevo trades on the NASDAQ under the ticker symbol "GEVO."
How were Gevo's earnings last quarter?
Gevo, Inc. (NASDAQ:GEVO) announced its earnings results on Thursday, August, 3rd. The company reported ($0.44) earnings per share for the quarter, beating analysts' consensus estimates of ($0.54) by $0.10. The business had revenue of $7.54 million for the quarter, compared to the consensus estimate of $5.63 million. Gevo had a negative net margin of 108.84% and a negative return on equity of 43.79%. View Gevo's Earnings History.
When will Gevo make its next earnings announcement?
Where is Gevo's stock going? Where will Gevo's stock price be in 2017?
2 equities research analysts have issued 1-year target prices for Gevo's stock. Their predictions range from $12.00 to $12.00. On average, they anticipate Gevo's stock price to reach $12.00 in the next year. View Analyst Ratings for Gevo.
What are analysts saying about Gevo stock?
Here are some recent quotes from research analysts about Gevo stock:
- 1. According to Zacks Investment Research, "Gevo, Inc. is a renewable chemicals and advanced biofuels company engaged in the development of biobased alternatives to petroleum-based products using a combination of synthetic biology and chemistry. The Company is focused on the commercialization of isobutanol, a naturally occurring four carbon alcohol with broad applications in large chemicals and fuels markets. Isobutanol can be used as a solvent and a gasoline blendstock and can be further processed into jet fuel and feedstocks for the production of synthetic rubber, plastics and polyesters. Markets served by the Company include solvents and coatings, materials, plastics and fibers, biojet blendstock, gasoline blendstock and other hydrocarbon fuels. " (9/18/2017)
- 2. HC Wainwright analysts commented, "We believe this revision has been driven with the goal of keeping cash burn low, as the cost of producing isobutanol at Luverne with the current infrastructure, exceeds the price that GEVO would receive for it. The company continues to manage isobutanol production to match market development efforts. We believe investors should expect some variability with isobutanol production levels in the near-term." (8/4/2017)
Who are some of Gevo's key competitors?
Some companies that are related to Gevo include Rex Energy Corporation (REXX), Aemetis (AMTX), Deep Down (DPDW), Superior Drilling Products (SDPI), Rentech (RTK), Pacific Drilling S.A. (PACD), Real Goods Solar (RGSE), U.S. Energy Corp. (USEG), Vantage Drilling (VTGDF), Triangle Petroleum (TPLM), Cardinal Energy Group (CEGX), Black Ridge Oil & Gas (ANFC), Ocean Rig UDW (ORIG), Lightstream Resources (LSTMF), New Western Energy Corp. (NWTR), 8point3 Energy Partners LP (CAFD), Atlas Resource Partners, L.P. (ARP) and C&J Energy Services (CJES).
Who are Gevo's key executives?
Gevo's management team includes the folowing people:
- Ruth I. Dreessen, Chairman of the Board
- Christopher Michael Ryan Ph.D., President, Chief Operating Officer, Chief Technology Officer
- Patrick R. Gruber Ph.D., Chief Executive Officer, Director
- Mike Willis, Chief Financial Officer, Executive Vice President of Corporate Development and Strategy
- Brett K E Lund J.D., Chief Legal Officer, General Counsel, and Secretary
- Greg Roda, Chief Commercial Officer
- William H. Baum, Director
- Johannes Minho Roth, Director
- Andy Marsh, Independent Director
- Gary W. Mize, Independent Director
Who owns Gevo stock?
Gevo's stock is owned by a number of of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (3.23%), Schwab Charles Investment Management Inc. (2.00%) and Virtu KCG Holdings LLC (1.21%). Company insiders that own Gevo stock include Brett Lund, Christopher Michael Ryan, Gregory Roda, Mike Willis and Patrick R Gruber. View Institutional Ownership Trends for Gevo.
Who bought Gevo stock? Who is buying Gevo stock?
How do I buy Gevo stock?
Shares of Gevo can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Gevo's stock price today?
One share of Gevo stock can currently be purchased for approximately $0.74.
MarketBeat Community Rating for Gevo (NASDAQ GEVO)MarketBeat's community ratings are surveys of what our community members think about Gevo and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Gevo (NASDAQ:GEVO) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 2 Buy Ratings |
| Consensus Rating: | Buy (Score: 3.00) |
| Consensus Price Target: | $12.00 (1,521.40% upside) |
Analysts' Ratings History for Gevo (NASDAQ:GEVO)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 8/9/2017 | Rodman & Renshaw | Reiterated Rating | Buy | $12.00 | Medium |  |
| 8/4/2017 | HC Wainwright | Set Price Target | Buy | $12.00 | High | |
| 3/30/2016 | Cowen and Company | Lower Price Target | Market Perform | $3.00 -> $1.00 | N/A | |
(Data available from 9/25/2015 forward)
Earnings History for Gevo (NASDAQ:GEVO)Earnings History by Quarter for Gevo (NASDAQ GEVO)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 11/13/2017 | | ($0.68) | | | | | N/A | |
| 8/3/2017 | Q2 2017 | ($0.54) | ($0.44) | $5.63 million | $7.54 million | View | Listen | |
| 5/9/2017 | Q1 2017 | ($0.57) | ($0.68) | $5.87 million | $5.62 million | View | Listen | |
| 3/29/2017 | Q4 2016 | ($0.96) | ($1.14) | | $5.84 million | View | Listen | |
| 11/14/2016 | Q3 2016 | ($0.09) | ($0.09) | $9.12 million | $6.90 million | View | Listen | |
| 8/9/2016 | Q2 | ($0.27) | ($0.15) | $8.90 million | $8.11 million | View | Listen | |
| 5/12/2016 | Q1 | ($0.32) | ($0.16) | $9.53 million | $6.32 million | View | Listen | |
| 3/29/2016 | Q4 | ($0.44) | ($0.44) | $9.12 million | $7.30 million | View | Listen | |
| 8/4/2015 | Q215 | ($0.81) | ($1.23) | $10.50 million | $8.90 million | View | Listen | |
| 5/12/2015 | Q115 | ($1.20) | ($0.88) | $6.10 million | $5.90 million | View | Listen | |
| 3/26/2015 | Q414 | ($0.14) | ($0.11) | | $9.50 million | View | Listen | |
| 5/14/2014 | Q114 | ($0.21) | ($0.18) | $1.70 million | $0.90 million | View | Listen | |
| 3/25/2014 | Q413 | ($0.34) | ($0.35) | $1.46 million | $1.70 million | View | Listen | |
| 11/5/2013 | Q313 | ($0.35) | ($0.34) | $1.09 million | $1.13 million | View | Listen | |
| 8/6/2013 | Q2 2013 | ($0.34) | ($0.35) | $0.78 million | $1.90 million | View | Listen | |
| 4/30/2013 | Q1 2013 | ($0.41) | ($0.45) | $1.06 million | $3.50 million | View | Listen | |
| 10/30/2012 | Q312 | ($0.43) | ($0.31) | $1.71 million | $0.60 million | View | N/A | |
| 5/1/2012 | | ($0.59) | ($0.74) | | | View | N/A | |
| 2/28/2012 | | ($0.48) | ($0.54) | | | View | N/A | |
| 8/1/2011 | | ($0.37) | ($0.48) | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Gevo (NASDAQ:GEVO)Current Year EPS Consensus Estimate: $-2 EPS
Next Year EPS Consensus Estimate: $-0.78 EPS
Dividend History for Gevo (NASDAQ:GEVO)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Gevo (NASDAQ:GEVO)Insider Ownership Percentage: 0.12%
Institutional Ownership Percentage: 13.14%
Insider Trades by Quarter for Gevo (NASDAQ:GEVO)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 12/12/2016 | Gregory Roda | Insider | Sell | 16 | $0.24 | $3.84 | |
| 12/12/2016 | Mike Willis | CFO | Sell | 21 | $0.24 | $5.04 | |
| 12/12/2016 | Patrick R Gruber | CEO | Sell | 108 | $0.24 | $25.92 | |
| 11/14/2016 | Christopher Michael Ryan | Insider | Sell | 121 | $0.44 | $53.24 | |
| 11/14/2016 | Mike Willis | CFO | Sell | 21 | $0.44 | $9.24 | |
| 11/14/2016 | Patrick R Gruber | CEO | Sell | 108 | $0.44 | $47.52 | |
| 10/12/2016 | Gregory Roda | Insider | Sell | 16 | $0.43 | $6.88 | |
| 10/12/2016 | Mike Willis | CFO | Sell | 21 | $0.43 | $9.03 | |
| 10/12/2016 | Patrick R Gruber | CEO | Sell | 108 | $0.43 | $46.44 | |
| 9/12/2016 | Christopher Michael Ryan | Insider | Sell | 141 | $0.50 | $70.50 | |
| 9/12/2016 | Mike Willis | CFO | Sell | 21 | $0.50 | $10.50 | |
| 9/12/2016 | Patrick R Gruber | CEO | Sell | 108 | $0.50 | $54.00 | |
| 9/6/2016 | Mike Willis | CFO | Sell | 48 | $0.58 | $27.84 | |
| 8/12/2016 | Gregory Roda | Insider | Sell | 16 | $0.56 | $8.96 | |
| 8/12/2016 | Mike Willis | CFO | Sell | 21 | $0.56 | $11.76 | |
| 8/12/2016 | Patrick R Gruber | CEO | Sell | 108 | $0.56 | $60.48 | |
| 8/3/2016 | Mike Willis | CFO | Sell | 48 | $0.54 | $25.92 | |
| 7/18/2016 | Christopher Michael Ryan | COO | Sell | 70 | $0.57 | $39.90 | |
| 7/12/2016 | Christopher Michael Ryan | COO | Sell | 121 | $0.58 | $70.18 | |
| 7/12/2016 | Gregory Roda | Insider | Sell | 16 | $0.58 | $9.28 | |
| 7/12/2016 | Mike Willis | CFO | Sell | 21 | $0.58 | $12.18 | |
| 7/12/2016 | Patrick R Gruber | CEO | Sell | 108 | $0.58 | $62.64 | |
| 7/5/2016 | Mike Willis | CFO | Sell | 48 | $0.61 | $29.28 | |
| 6/20/2016 | Christopher Michael Ryan | COO | Sell | 70 | $0.61 | $42.70 | |
| 6/13/2016 | Christopher Michael Ryan | COO | Sell | 121 | $0.44 | $53.24 | |
| 6/13/2016 | Gregory Roda | Insider | Sell | 16 | $0.44 | $7.04 | |
| 6/13/2016 | Mike Willis | CFO | Sell | 21 | $0.44 | $9.24 | |
| 6/13/2016 | Patrick R Gruber | CEO | Sell | 108 | $0.44 | $47.52 | |
| 6/3/2016 | Mike Willis | CFO | Sell | 48 | $0.33 | $15.84 | |
| 5/18/2016 | Christopher Michael Ryan | COO | Sell | 70 | $0.29 | $20.30 | |
| 5/12/2016 | Christopher Michael Ryan | COO | Sell | 121 | $0.30 | $36.30 | |
| 5/12/2016 | Gregory Roda | Insider | Sell | 16 | $0.30 | $4.80 | |
| 5/12/2016 | Mike Willis | CFO | Sell | 21 | $0.30 | $6.30 | |
| 5/12/2016 | Patrick R Gruber | CEO | Sell | 108 | $0.30 | $32.40 | |
| 5/3/2016 | Mike Willis | CFO | Sell | 48 | $0.26 | $12.48 | |
| 4/18/2016 | Christopher Michael Ryan | COO | Sell | 70 | $0.26 | $18.20 | |
| 4/12/2016 | Christopher Michael Ryan | COO | Sell | 121 | $0.26 | $31.46 | |
| 4/12/2016 | Gregory Roda | Insider | Sell | 16 | $0.26 | $4.16 | |
| 4/12/2016 | Mike Willis | CFO | Sell | 21 | $0.26 | $5.46 | |
| 4/12/2016 | Patrick R Gruber | CEO | Sell | 108 | $0.26 | $28.08 | |
| 4/4/2016 | Mike Willis | CFO | Sell | 48 | $0.24 | $11.52 | |
| 3/18/2016 | Christopher Michael Ryan | COO | Sell | 70 | $0.40 | $28.00 | |
| 3/15/2016 | Christopher Michael Ryan | COO | Sell | 142 | $0.36 | $51.12 | |
| 3/15/2016 | Patrick R Gruber | CEO | Sell | 162 | $0.36 | $58.32 | |
| 3/14/2016 | Christopher Michael Ryan | COO | Sell | 121 | $0.37 | $44.77 | |
| 3/14/2016 | Gregory Roda | Insider | Sell | 16 | $0.37 | $5.92 | |
| 3/14/2016 | Mike Willis | CFO | Sell | 21 | $0.37 | $7.77 | |
| 3/14/2016 | Patrick R Gruber | CEO | Sell | 108 | $0.37 | $39.96 | |
| 3/3/2016 | Mike Willis | CFO | Sell | 48 | $0.40 | $19.20 | |
| 2/18/2016 | Christopher Michael Ryan | COO | Sell | 70 | $0.40 | $28.00 | |
| 2/16/2016 | Christopher Michael Ryan | COO | Sell | 142 | $0.40 | $56.80 | |
| 2/16/2016 | Patrick R. Gruber | CEO | Sell | 3,139 | $0.40 | $1,255.60 | |
| 2/12/2016 | Christopher Michael Ryan | COO | Sell | 121 | $0.34 | $41.14 | |
| 2/12/2016 | Gregory Roda | Insider | Sell | 16 | $0.34 | $5.44 | |
| 2/12/2016 | Mike Willis | CFO | Sell | 21 | $0.34 | $7.14 | |
| 2/12/2016 | Patrick R Gruber | CEO | Sell | 108 | $0.34 | $36.72 | |
| 2/3/2016 | Mike Willis | CFO | Sell | 48 | $0.39 | $18.72 | |
| 1/21/2016 | Christopher Michael Ryan | COO | Sell | 212 | $0.37 | $78.44 | |
| 1/21/2016 | Patrick R Gruber | CEO | Sell | 162 | $0.37 | $59.94 | |
| 1/12/2016 | Christopher Michael Ryan | COO | Sell | 141 | $0.41 | $57.81 | |
| 1/12/2016 | Gregory Roda | Insider | Sell | 16 | $0.41 | $6.56 | |
| 1/12/2016 | Mike Willis | CFO | Sell | 21 | $0.41 | $8.61 | |
| 1/12/2016 | Patrick R Gruber | CEO | Sell | 108 | $0.41 | $44.28 | |
| 1/4/2016 | Mike Willis | CFO | Sell | 48 | $0.61 | $29.28 | |
| 12/18/2015 | Christopher Michael Ryan | COO | Sell | 70 | $0.60 | $42.00 | |
| 12/15/2015 | Christopher Michael Ryan | COO | Sell | 142 | $0.65 | $92.30 | |
| 12/15/2015 | Patrick R Gruber | CEO | Sell | 162 | $0.65 | $105.30 | |
| 12/14/2015 | Christopher Michael Ryan | COO | Sell | 121 | $0.68 | $82.28 | |
| 12/14/2015 | Mike Willis | CFO | Sell | 21 | $0.68 | $14.28 | |
| 12/14/2015 | Patrick R Gruber | CEO | Sell | 108 | $0.68 | $73.44 | |
| 10/19/2015 | Christopher Michael Ryan | COO | Sell | 70 | $2.17 | $151.90 | |
| 10/12/2015 | Brett Lund | EVP | Sell | 42 | $2.10 | $88.20 | |
| 10/12/2015 | Christopher Michael Ryan | COO | Sell | 121 | $2.10 | $254.10 | |
| 10/12/2015 | Gregory Roda | Insider | Sell | 16 | $2.09 | $33.44 | |
| 10/12/2015 | Patrick R Gruber | CEO | Sell | 108 | $2.09 | $225.72 | |
| 7/8/2015 | Brett Lund | EVP | Sell | 62,574 | $2.33 | $145,797.42 | |
| 7/8/2015 | Christopher Michael Ryan | COO | Sell | 55,329 | $2.34 | $129,469.86 | |
| 7/8/2015 | Gregory Roda | Insider | Sell | 46,865 | $2.46 | $115,287.90 | |
| 7/8/2015 | Mike Willis | CFO | Sell | 50,001 | $2.29 | $114,502.29 | |
| 7/8/2015 | Patrick R Gruber | CEO | Sell | 96,982 | $2.33 | $225,968.06 | |
| 6/15/2015 | Mike Willis | CFO | Sell | 69 | $3.72 | $256.68 | |
| 5/18/2015 | Christopher Michael Ryan | COO | Sell | 142 | $3.89 | $552.38 | |
| 5/7/2015 | Patrick R Gruber | CEO | Sell | 1,432 | $4.50 | $6,444.00 | |
| 4/16/2015 | Brett Lund | EVP | Sell | 4,238 | $0.18 | $762.84 | |
| 4/16/2015 | Christopher Michael Ryan | COO | Sell | 2,119 | $0.18 | $381.42 | |
| 3/17/2015 | Brett Lund | EVP | Sell | 4,718 | $0.24 | $1,132.32 | |
| 3/17/2015 | Christopher Michael Ryan | COO | Sell | 2,558 | $0.24 | $613.92 | |
| 3/9/2015 | Patrick R Gruber | CEO | Sell | 7,308 | $0.30 | $2,192.40 | |
| 2/19/2015 | Christopher Michael Ryan | COO | Sell | 1,042 | $0.23 | $239.66 | |
| 2/18/2015 | Brett Lund | EVP | Sell | 4,717 | $0.26 | $1,226.42 | |
| 2/13/2015 | Christopher Michael Ryan | COO | Sell | 1,809 | $0.22 | $397.98 | |
| 1/29/2015 | Christopher Michael Ryan | COO | Sell | 1,042 | $0.14 | $145.88 | |
| 1/16/2015 | Brett Lund | EVP | Sell | 4,238 | $0.29 | $1,229.02 | |
| 1/16/2015 | Christopher Michael Ryan | COO | Sell | 2,119 | $0.29 | $614.51 | |
| 1/16/2015 | Patrick R Gruber | CEO | Sell | 6,054 | $0.31 | $1,876.74 | |
| 1/13/2015 | Brett Lund | EVP | Sell | 619 | $0.32 | $198.08 | |
| 1/13/2015 | Christopher Michael Ryan | COO | Sell | 1,809 | $0.32 | $578.88 | |
| 1/13/2015 | Gregory Roda | Insider | Sell | 238 | $0.33 | $78.54 | |
| 1/13/2015 | Mike Willis | CFO | Sell | 306 | $0.33 | $100.98 | |
| 12/19/2014 | Christopher Michael Ryan | COO | Sell | 1,042 | $0.30 | $312.60 | |
| 12/17/2014 | Patrick R Gruber | CEO | Sell | 7,309 | $0.30 | $2,192.70 | |
| 12/16/2014 | Brett Lund | EVP | Sell | 5,337 | $0.27 | $1,440.99 | |
| 12/16/2014 | Christopher Michael Ryan | COO | Sell | 4,367 | $0.27 | $1,179.09 | |
| 12/15/2014 | Patrick R Gruber | CEO | Sell | 4,047 | $0.30 | $1,214.10 | |
| 11/19/2014 | Brett Lund | EVP | Sell | 10,673 | $0.40 | $4,269.20 | |
| 11/19/2014 | Christopher Michael Ryan | COO | Sell | 3,601 | $0.40 | $1,440.40 | |
| 11/13/2014 | Christopher Michael Ryan | COO | Sell | 1,809 | $0.36 | $651.24 | |
| 9/22/2014 | Christopher Michael Ryan | COO | Sell | 1,402 | $0.40 | $560.80 | |
| 9/16/2014 | Brett Lund | EVP | Sell | 5,337 | $0.43 | $2,294.91 | |
| 9/16/2014 | Christopher Michael Ryan | COO | Sell | 4,367 | $0.43 | $1,877.81 | |
| 9/16/2014 | Patrick R Gruber | CEO | Sell | 11,353 | $0.43 | $4,881.79 | |
| 8/20/2014 | Christopher Michael Ryan | COO | Sell | 1,042 | $0.46 | $479.32 | |
| 8/18/2014 | Brett Lund | EVP | Sell | 4,238 | $0.46 | $1,949.48 | |
| 8/18/2014 | Christopher Michael Ryan | COO | Sell | 4,368 | $0.47 | $2,052.96 | |
| 8/18/2014 | Patrick R Gruber | CEO | Sell | 11,356 | $0.47 | $5,337.32 | |
| 8/15/2014 | Brett Lund | EVP | Sell | 1,099 | $0.47 | $516.53 | |
| 8/13/2014 | Gregory Roda | Insider | Sell | 238 | $0.49 | $116.62 | |
| 8/13/2014 | Mike Willis | CFO | Sell | 306 | $0.48 | $146.88 | |
| 7/21/2014 | Christopher Michael Ryan | COO | Sell | 1,042 | $0.74 | $771.08 | |
| 7/16/2014 | Brett Lund | Insider | Sell | 4,238 | $0.78 | $3,305.64 | |
| 7/16/2014 | Christopher Michael Ryan | COO | Sell | 4,367 | $0.80 | $3,493.60 | |
| 7/16/2014 | Patrick R Gruber | CEO | Sell | 11,355 | $0.79 | $8,970.45 | |
| 7/15/2014 | Brett Lund | Insider | Sell | 1,098 | $0.81 | $889.38 | |
| 7/15/2014 | Christopher Michael Ryan | COO | Sell | 2,248 | $0.81 | $1,820.88 | |
| 7/15/2014 | Patrick R Gruber | CEO | Sell | 5,300 | $0.80 | $4,240.00 | |
| 6/19/2014 | Christopher Michael Ryan | COO | Sell | 3,600 | $0.95 | $3,420.00 | |
| 6/18/2014 | Gregory Roda | Insider | Sell | 4,298 | $0.94 | $4,040.12 | |
| 6/18/2014 | Mike Willis | CFO | Sell | 18,167 | $0.94 | $17,076.98 | |
| 6/17/2014 | Brett Lund | EVP | Sell | 4,718 | $0.95 | $4,482.10 | |
| 6/17/2014 | Patrick R Gruber | CEO | Sell | 7,309 | $0.96 | $7,016.64 | |
| 6/13/2014 | Christopher Michael Ryan | COO | Sell | 1,809 | $0.95 | $1,718.55 | |
| 6/13/2014 | Patrick R Gruber | CEO | Sell | 2,023 | $0.95 | $1,921.85 | |
| 5/29/2014 | Brett Lund | EVP | Sell | 28,571 | $0.95 | $27,142.45 | |
| 5/29/2014 | Christopher Michael Ryan | COO | Sell | 29,451 | $0.95 | $27,978.45 | |
| 5/29/2014 | Patrick R Gruber | CEO | Sell | 54,945 | $0.92 | $50,549.40 | |
| 5/16/2014 | Brett Lund | EVP | Sell | 4,718 | $0.97 | $4,576.46 | |
| 5/16/2014 | Patrick Gruber | CEO | Sell | 7,308 | $0.98 | $7,161.84 | |
| 4/22/2014 | Christopher Michael Ryan | COO | Sell | 1,042 | $1.00 | $1,042.00 | |
| 4/16/2014 | Brett Lund | EVP | Sell | 4,717 | $0.81 | $3,820.77 | |
| 4/16/2014 | Christopher Michael Ryan | COO | Sell | 2,558 | $0.81 | $2,071.98 | |
| 4/16/2014 | Patrick Gruber | CEO | Sell | 7,310 | $0.81 | $5,921.10 | |
| 3/19/2014 | Christopher Michael Ryan | COO | Sell | 3,601 | $1.35 | $4,861.35 | |
| 3/18/2014 | Brett Lund | EVP | Sell | 4,718 | $1.35 | $6,369.30 | |
| 3/18/2014 | Patrick Gruber | CEO | Sell | 7,309 | $1.35 | $9,867.15 | |
| 2/19/2014 | Brett Lund | EVP | Sell | 4,718 | $1.27 | $5,991.86 | |
| 2/19/2014 | Christopher Michael Ryan | COO | Sell | 3,600 | $1.27 | $4,572.00 | |
| 2/19/2014 | Patrick Gruber | CEO | Sell | 7,308 | $1.27 | $9,281.16 | |
| 1/24/2014 | Christopher Michael Ryan | COO | Sell | 1,514 | $1.32 | $1,998.48 | |
| 1/16/2014 | Brett Lund | EVP | Sell | 4,717 | $0.13 | $613.21 | |
| 1/16/2014 | Christopher Michael Ryan | COO | Sell | 2,558 | $1.29 | $3,299.82 | |
| 1/16/2014 | Patrick Gruber | CEO | Sell | 7,310 | $1.29 | $9,429.90 | |
| 12/19/2013 | Christopher Michael Ryan | COO | Sell | 3,600 | $1.19 | $4,284.00 | |
| 12/17/2013 | Brett Lund | EVP | Sell | 4,718 | $1.18 | $5,567.24 | |
| 12/17/2013 | Patrick Gruber | CEO | Sell | 7,308 | $1.18 | $8,623.44 | |
| 11/19/2013 | Christopher Michael Ryan | COO | Sell | 3,600 | $1.55 | $5,580.00 | |
| 10/21/2013 | Christopher Michael Ryan | COO | Sell | 3,124 | $1.83 | $5,716.92 | |
| 10/16/2013 | Brett Lund | EVP | Sell | 4,718 | $1.82 | $8,586.76 | |
| 10/16/2013 | Christopher Michael Ryan | COO | Sell | 2,559 | $1.81 | $4,631.79 | |
| 10/16/2013 | Patrick R Gruber | CEO | Sell | 7,309 | $1.81 | $13,229.29 | |
| 9/24/2013 | Brett Lund | EVP | Sell | 6,861 | $1.91 | $13,104.51 | |
| 9/18/2013 | Brett Lund | EVP | Sell | 66,717 | $2.02 | $134,768.34 | |
| 9/17/2013 | Christopher Michael Ryan | COO | Sell | 2,558 | $1.95 | $4,988.10 | |
| 9/17/2013 | Mark Smith | CFO | Sell | 2,470 | $1.95 | $4,816.50 | |
| 9/17/2013 | Patrick Gruber | CEO | Sell | 7,308 | $1.95 | $14,250.60 | |
| 8/16/2013 | Brett Lund | EVP | Sell | 6,718 | $1.77 | $11,890.86 | |
| 8/16/2013 | Christopher Michael Ryan | COO | Sell | 2,558 | $1.75 | $4,476.50 | |
| 8/16/2013 | Mark Smith | CFO | Sell | 2,470 | $1.75 | $4,322.50 | |
| 8/16/2013 | Patrick Gruber | CEO | Sell | 3,290 | $1.75 | $5,757.50 | |
| 7/16/2013 | Brett Lund | EVP | Sell | 6,718 | $1.98 | $13,301.64 | |
| 7/16/2013 | Christopher Michael Ryan | COO | Sell | 2,558 | $1.97 | $5,039.26 | |
| 7/16/2013 | Mark L Smith | CFO | Sell | 2,470 | $1.97 | $4,865.90 | |
| 7/16/2013 | Patrick R Gruber | CEO | Sell | 3,288 | $1.97 | $6,477.36 | |
| 6/18/2013 | Brett Lund | EVP | Sell | 13,188 | $2.12 | $27,958.56 | |
| 6/18/2013 | Christopher Michael Ryan | COO | Sell | 6,794 | $2.11 | $14,335.34 | |
| 6/18/2013 | Mark L Smith | CFO | Sell | 13,060 | $2.19 | $28,601.40 | |
| 5/30/2013 | Brett Lund | EVP | Sell | 2,995 | $1.77 | $5,301.15 | |
| 11/13/2012 | Brant Demuth | EVP | Buy | 6,500 | $1.57 | $10,205.00 | |
| 11/13/2012 | Patrick R Gruber | CEO | Buy | 10,000 | $1.57 | $15,700.00 | |
| 11/2/2012 | Christopher Michael Ryan | COO | Buy | 9,600 | $2.04 | $19,584.00 | |
| 11/2/2012 | Patrick R Gruber | CEO | Buy | 24,200 | $2.03 | $49,126.00 | |
| 8/16/2012 | Patrick R Gruber | CEO | Buy | 13,300 | $3.72 | $49,476.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Gevo (NASDAQ:GEVO)
Latest Headlines for Gevo (NASDAQ:GEVO)
| Source: |
|
| Date | Headline |
|---|
 | Today's Research Reports on Trending Tickers: Gevo and Ocera Therapeutics
finance.yahoo.com - September 22 at 2:36 PM |
| ETFs with exposure to Gevo, Inc. : September 22, 2017
finance.yahoo.com - September 22 at 2:36 PM |
 | Gevo, Inc. (GEVO) Lifted to "Buy" at Zacks Investment Research
www.americanbankingnews.com - September 18 at 7:00 PM |
| Is It Time To Buy Gevo Inc (GEVO)?
finance.yahoo.com - September 18 at 6:34 PM |
| Gevo, Inc. (GEVO) Downgraded by Zacks Investment Research to "Hold"
www.americanbankingnews.com - September 14 at 10:35 PM |
 | Gevo to Participate in BEI AlphaDirect Virtual Conference Series on September 7, 2017 - GlobeNewswire (press release)
globenewswire.com - September 6 at 11:54 PM |
| Gevo, Inc. (GEVO) Downgraded to "Hold" at Zacks Investment Research
www.americanbankingnews.com - September 6 at 11:38 PM |
| Gevo to Participate in BEI AlphaDirect Virtual Conference Series on September 7, 2017
finance.yahoo.com - September 6 at 1:10 AM |
| BioEconomy Investor Will be Hosting Gevo, Inc. CEO Dr. Patrick Gruber on September 7th, 2017 as Part of the BEI AlphaDirect Virtual Conference Series
finance.yahoo.com - September 6 at 1:10 AM |
| Gevo, Inc. (GEVO) Lifted to Sell at ValuEngine
www.americanbankingnews.com - September 3 at 10:56 AM |
| Gevo, Inc. (GEVO) Upgraded to "Buy" by Zacks Investment Research
www.americanbankingnews.com - August 29 at 11:58 PM |
| Gevo Announces Participation at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City ... - GlobeNewswire (press release)
globenewswire.com - August 29 at 7:27 PM |
| Gevo Announces Participation at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City on September 11th, 2017
finance.yahoo.com - August 29 at 7:27 PM |
| ETFs with exposure to Gevo, Inc. : August 25, 2017
finance.yahoo.com - August 26 at 2:44 AM |
| Gevo, Inc. (GEVO) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - August 23 at 10:22 PM |
| Gevo, Inc. (GEVO) Cut to "Hold" at Zacks Investment Research
www.americanbankingnews.com - August 23 at 12:34 AM |
| Head to Head Comparison: Gevo (GEVO) versus Ceres (CERE)
www.americanbankingnews.com - August 22 at 10:32 AM |
| Financial Contrast: Ceres (CERE) & Gevo (GEVO)
www.americanbankingnews.com - August 20 at 12:34 PM |
| Financial Comparison: Ceres (CERE) versus Gevo (GEVO)
www.americanbankingnews.com - August 19 at 12:30 PM |
| Gevo, Inc. :GEVO-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017
finance.yahoo.com - August 16 at 7:06 PM |
| Analyzing Ceres (CERE) & Gevo (GEVO)
www.americanbankingnews.com - August 15 at 8:30 PM |
| Reviewing Gevo (NASDAQ:GEVO) & Ceres (CERE)
www.americanbankingnews.com - August 13 at 2:26 AM |
| Ceres (CERE) and Gevo (NASDAQ:GEVO) Head-To-Head Analysis
www.americanbankingnews.com - August 12 at 6:18 PM |
| Ceres (CERE) versus Gevo (NASDAQ:GEVO) Head to Head Contrast
www.americanbankingnews.com - August 12 at 2:26 PM |
| Rodman & Renshaw Reiterates Buy Rating for Gevo, Inc. (NASDAQ:GEVO)
www.americanbankingnews.com - August 9 at 9:44 PM |
| Gevo, Inc. (GEVO) Upgraded to Buy at Zacks Investment Research
www.americanbankingnews.com - August 8 at 10:50 PM |
| Ceres (CERE) vs. Gevo (NASDAQ:GEVO) Critical Comparison
www.americanbankingnews.com - August 8 at 10:18 PM |
| Financial Comparison: Ceres (CERE) and Gevo (NASDAQ:GEVO)
www.americanbankingnews.com - August 4 at 10:16 PM |
| Gevo, Inc. (NASDAQ:GEVO) Releases Quarterly Earnings Results, Beats Expectations By $0.10 EPS
www.americanbankingnews.com - August 4 at 7:30 PM |
| Edited Transcript of GEVO earnings conference call or presentation 3-Aug-17 8:30pm GMT
finance.yahoo.com - August 4 at 7:15 PM |
| Gevo, Inc. (NASDAQ:GEVO) Given "Buy" Rating at HC Wainwright
www.americanbankingnews.com - August 4 at 10:08 AM |
| Gevo Reports 2nd Quarter 2017 Financial Results - GlobeNewswire (press release)
globenewswire.com - August 3 at 4:22 PM |
| Gevo Reports 2nd Quarter 2017 Financial Results
finance.yahoo.com - August 3 at 4:22 PM |
| Comparing Ceres (CERE) & Gevo (NASDAQ:GEVO)
www.americanbankingnews.com - July 28 at 12:28 AM |
| Analyzing Gevo (GEVO) and Ceres (CERE)
www.americanbankingnews.com - July 27 at 6:39 PM |
| Critical Contrast: Gevo (NASDAQ:GEVO) and Ceres (CERE)
www.americanbankingnews.com - July 27 at 12:31 PM |
| Head to Head Survey: Gevo (NASDAQ:GEVO) and Ceres (CERE)
www.americanbankingnews.com - July 26 at 11:59 PM |
| Gevo, Inc. (NASDAQ:GEVO) Receives Buy Rating from HC Wainwright
www.americanbankingnews.com - July 26 at 4:31 PM |
 | Gevo joins with India's Praj to commercialize isobutanol technology - Seeking Alpha
seekingalpha.com - July 25 at 7:17 PM |
| Praj-Gevo Joint Development Agreement to Enter Commercialization Phase
finance.yahoo.com - July 25 at 7:17 PM |
| Gevo to Host Conference Call to Report Second Quarter Financial Results on August 3, 2017 - GlobeNewswire (press release)
globenewswire.com - July 20 at 9:50 PM |
 | BioEconomy Investor Discusses the Changing Government Landscape and Recently Accomplished Milestones with ... - Baystreet.ca
www.baystreet.ca - July 20 at 5:42 AM |
| BioEconomy Investor Discusses the Changing Government Landscape and Recently Accomplished Milestones with Gevo CEO Dr. Patrick R. Gruber
finance.yahoo.com - July 19 at 7:41 PM |
| Reviewing Gevo (GEVO) and Green Plains Partners (GPP)
www.americanbankingnews.com - July 13 at 12:24 AM |
| Gevo (GEVO) vs. Green Plains Partners (GPP) Head to Head Comparison
www.americanbankingnews.com - July 12 at 10:31 PM |
| ETFs with exposure to Gevo, Inc. : July 11, 2017
finance.yahoo.com - July 11 at 8:09 PM |
| ETFs with exposure to Gevo, Inc. : June 29, 2017
finance.yahoo.com - June 29 at 10:41 PM |
| Gevo Announces Closing of Whitebox Debt Exchange - GlobeNewswire (press release)
globenewswire.com - June 20 at 6:08 PM |
| Gevo Announces Closing of Whitebox Debt Exchange
finance.yahoo.com - June 20 at 6:08 PM |
| Gevo Announces Stockholder Vote to Clear Way for Whitebox Debt Exchange - GlobeNewswire (press release)
globenewswire.com - June 17 at 5:50 PM |
Gevo (GEVO) Chart for Monday, September, 25, 2017
